Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

50.37
+1.002.03%
Post-market: 50.900.5300+1.05%19:59 EDT
Volume:35.99M
Turnover:1.81B
Market Cap:73.00B
PE:20.41
High:50.90
Open:49.22
Low:49.01
Close:49.37
52wk High:109.50
52wk Low:42.20
Shares:1.45B
Float Shares:1.45B
Volume Ratio:2.16
T/O Rate:2.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.93
PE(LYR):25.96

Loading ...

U.S. Research ROUNDUP-Apple, Amazon, Mastercard

Reuters
·
Jul 31

Penumbra Q2 FY26 Net Income Falls to 34.81 Million; Revenue Rises 14.9% to 390 Million

Reuters
·
Jul 31

Penumbra Q2 Revenue Slightly Beats Estimates, Helped by Product Segment Increase

Reuters
·
Jul 31

Cerus Q2 Adjusted Ebitda Misses Estimates, Raises 2026 Outlook

Reuters
·
Jul 31

Penumbra - Will not Provide Full Year 2026 Guidance or Host Conference Call Due to Pending Acquisition

THOMSON REUTERS
·
Jul 31

Boston Scientific's Watchman Slowdown Raises Utilization Questions, Oppenheimer Says

MT Newswires Live
·
Jul 31

Boston Scientific Lowered Full-Year Guidance on Headwinds in Electrophysiology, Watchman Portfolios, RBC Says

MT Newswires Live
·
Jul 30

Movement Alert|Boston Scientific Falls 3.06% in Regular Trading, Multiple Banks Cut Price Targets Post-Earnings on Watchman Weakness

Market Focus
·
Jul 30

UBS Adjusts Boston Scientific Price Target to $67 From $74, Maintains Buy Rating

MT Newswires Live
·
Jul 30

Deutsche Bank Adjusts Boston Scientific PT to $60 From $75, Maintains Buy Rating

MT Newswires Live
·
Jul 30

Baxter Q2 Revenue Rises 5%, Beats Analyst Estimates

Reuters
·
Jul 30

Boston Scientific Corp : TD Cowen Cuts Target Price to $56 from $61

THOMSON REUTERS
·
Jul 30

U.S. Research ROUNDUP-Equinix, Meta, S&P Global

Reuters
·
Jul 30

Boston Scientific Corp : RBC Cuts Target Price to $70 from $85

THOMSON REUTERS
·
Jul 30

Boston Scientific Balances Earnings Beat With Cautious Outlook

TIPRANKS
·
Jul 30

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Teladoc (TDOC) and Boston Scientific (BSX)

TIPRANKS
·
Jul 30

Boston Scientific Posts Strong Q2 Growth in Interventional Cardiology and Neuromodulation Divisions

Deep News
·
Jul 30

Pulmonx Corp Q2 Revenue Falls, but Beats Estimates

Reuters
·
Jul 30

Conmed Q2 Sales, Adjusted Profit Beat on Organinc Platform Growth

Reuters
·
Jul 30

Glaukos Q2 Sales Jump 50%; Raises Net Sales Forecast

Reuters
·
Jul 30